Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest update is out from Syncom Formulation (India) Ltd. ( (IN:SYNCOMF) ).
Syncom Formulations (India) Ltd. has announced amendments to its Articles of Association (AOA) and Memorandum of Association (MOA), subject to shareholder approval at the upcoming Annual General Meeting. These changes include new clauses related to power purchase agreements and project definitions, indicating a strategic shift towards renewable energy initiatives. This move could potentially enhance the company’s operational scope and align its business model with sustainable energy practices, impacting its industry positioning and stakeholder interests.
More about Syncom Formulation (India) Ltd.
Syncom Formulations (India) Ltd. operates in the pharmaceutical industry, focusing on the formulation and distribution of medicinal products. The company is known for its diverse range of healthcare solutions and aims to strengthen its market position through strategic amendments and expansions.
Average Trading Volume: 585,366
Technical Sentiment Signal: Buy
Current Market Cap: 16.86B INR
Find detailed analytics on SYNCOMF stock on TipRanks’ Stock Analysis page.